Symbiotec Pharmalab Closes Trading Window for Q2 FY27

Symbiotec Pharmalab Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in effect for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026. The company is adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct. The specific date for the Board of Directors meeting to approve these results will be communicated later. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.